Silence Therapeutics (SLN) EPS (Weighted Average and Diluted) (2024 - 2026)
Silence Therapeutics' (SLN) quarterly EPS (Weighted Average and Diluted) came in at -$0.11 in Q1 2026, up 45.0% year-on-year from -$0.08 in Q1 2025, and down 22.22% quarter-over-quarter from -$0.09 in Q4 2025.
Silence Therapeutics (SLN) EPS (Weighted Average and Diluted) (2024 - 2026) Analysis & Trends
Silence Therapeutics has disclosed EPS (Weighted Average and Diluted) across 3 years of filings, most recently posting -$0.11 for Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.11, up 45.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.54 (down 8.0% YoY), and the FY2025 annual result was -$0.63, down 90.91% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.11 for Q1 2026 at Silence Therapeutics, down from -$0.09 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.09 in Q4 2024 to a low of -$0.25 in Q3 2024.
- The 3-year median for EPS (Weighted Average and Diluted) is -$0.14 (2024), against an average of -$0.12.
- Across the five-year window, EPS (Weighted Average and Diluted) slumped 900.0% in 2025 and surged 45.0% in 2026, its largest moves.
- Silence Therapeutics' EPS (Weighted Average and Diluted) stood at $0.09 in 2024, then slumped by 200.0% to -$0.09 in 2025, then dropped by 22.22% to -$0.11 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.11 (Q1 2026), -$0.09 (Q4 2025), and -$0.15 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Silence Therapeutics | 966.41 Mn | 896.33 Mn | 411,000.00 | -0.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.11 |
| Dec 31, 2025 | -0.09 |
| Sep 30, 2025 | -0.15 |
| Jun 30, 2025 | -0.19 |
| Mar 31, 2025 | -0.20 |
| Dec 31, 2024 | 0.09 |
| Sep 30, 2024 | -0.25 |
| Jun 30, 2024 | -0.14 |
| Mar 31, 2024 | -0.02 |